Find a Trial
Trial Summary
| Protocol No. | CTO-SNDX-6352-0504 | ||
|---|---|---|---|
| Status | OPEN TO ACCRUAL | ||
| Principal Investigator | Abu Zaid, Mohammad | ||
| Scope | National | ||
| Phase | Phase II | ||
| Age Group | Adults and Children | ||
| Title | AGAVE-201, A Phase 2, Open-label, Randomized, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Axatilimab at 3 Different Doses in Patients with Recurrent or Refractory Active Chronic Graft Versus Host Disease who have Received at least 2 Lines of Systemic Therapy | ||
| Applicable Disease Sites | Any Site | ||
| Participating Institutions | Indiana University (IU) | ||
| Treatment Type | Treatment | ||
| Contact | Ann J. Blakley, | Phone: Pager: +1 317-312-3102 Email: ajblakle@iu.edu | |